Temporal quantitative proteomics of mGluR-induced protein translation and phosphorylation in neurons CAGH van Gelder, R Penning, TS Veth, LAE Catsburg, CC Hoogenraad, ... Molecular & Cellular Proteomics 19 (12), 1952-1968, 2020 | 13 | 2020 |
Identification of common and distinct origins of human serum and breastmilk IgA1 by mass spectrometry-based clonal profiling KA Dingess, M Hoek, DMH van Rijswijk, S Tamara, MA den Boer, T Veth, ... Cellular & Molecular Immunology 20 (1), 26-37, 2023 | 12 | 2023 |
Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses M Brinkkemper, TS Veth, PJM Brouwer, H Turner, M Poniman, JA Burger, ... Iscience 25 (12), 2022 | 8 | 2022 |
Elucidating Fibroblast Growth Factor–Induced Kinome Dynamics Using Targeted Mass Spectrometry and Dynamic Modeling TS Veth, C Francavilla, AJR Heck, M Altelaar Molecular & Cellular Proteomics 22 (8), 2023 | 6 | 2023 |
CD5L is a canonical component of circulatory IgM N Oskam, MA den Boer, MV Lukassen, P Ooijevaar-de Heer, TS Veth, ... Proceedings of the National Academy of Sciences 120 (50), e2311265120, 2023 | 4 | 2023 |
Optimized Suspension Trapping Method for Phosphoproteomics Sample Preparation F Wang, T Veth, M Kuipers, M Altelaar, KE Stecker Analytical Chemistry 95 (25), 9471-9479, 2023 | 4 | 2023 |
Mapping prohormone processing by proteases in human enteroendocrine cells using genetically engineered organoid models J Beumer, J Bauzá-Martinez, TS Veth, V Geurts, C Boot, H Gilliam-Vigh, ... Proceedings of the National Academy of Sciences 119 (46), e2212057119, 2022 | 4 | 2022 |
Multilevel Plasticity and Altered Glycosylation Drive Aggressiveness in Hypoxic and Glucose-Deprived Bladder Cancer Cells A Peixoto, D Ferreira, A Miranda, M Relvas-Santos, R Freitas, TS Veth, ... bioRxiv, 2023.10. 21.561355, 2023 | 1 | 2023 |
Assessment of Kinome-Wide Activity Remodeling upon Picornavirus Infection TS Veth, LV Nouwen, M Zwaagstra, H Lyoo, KA Wierenga, B Westendorp, ... Molecular & Cellular Proteomics 23 (5), 2024 | | 2024 |
Innovative strategies for measuring kinase activity to accelerate the next wave of novel kinase inhibitors TS Veth, NM Kannegieter, EL de Graaf, R Ruijtenbeek, J Joore, A Ressa, ... Drug Discovery Today, 103907, 2024 | | 2024 |
Dissecting fibroblast growth factor-induced endocrine therapy resistance in breast cancer cells M Altelaar, T Veth, A Piskopou | | 2023 |